Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-024762

Chief Medical Officer gave up 16,520 shares (to pay taxes)

  • Chief Medical Officer acquired 31,246 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2026-03-05 Option exercise +31,246 148,477 D
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2026-03-05 Shares withheld for taxes −16,520 $4.58 $75,662 131,957 D
Derivatives
GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer 2026-03-05 Option exercise · Restricted Stock Units −31,246 62,504 D
Loading xslF345X05/tm268187-3_4seq1.xml…